Mohindru Mani has filed 7 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 600000 shares of Cardiff Oncology, Inc. ($CRDF) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Cardiff Oncology, Inc. | $CRDF | Mohindru Mani | Chief Executive Officer | A | Stock Options | 600000 | $0.00 | 968,766.0000 | 67,360,564 | 162.70% | 0.89% |
| Feb. 17, 2026 | Cardiff Oncology, Inc. | $CRDF | Mohindru Mani | Interim CEO | A | Stock Options | 200000 | $0.00 | 368,766.0000 | 67,360,564 | 118.51% | 0.30% |
| June 26, 2025 | Cardiff Oncology, Inc. | $CRDF | Mohindru Mani | Director | A | Stock Options | 40565 | $0.00 | 168,766.0000 | 66,524,294 | 31.64% | 0.06% |
| June 11, 2025 | CytomX Therapeutics, Inc. | $CTMX | Mohindru Mani | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 80,099,889 | 9999.99% | 0.05% |
| June 27, 2024 | Cardiff Oncology, Inc. | $CRDF | Mohindru Mani | Director | A | Stock Options | 29700 | $0.00 | 128,201.0000 | 0 | 30.15% | 0.00% |
| May 15, 2024 | CytomX Therapeutics, Inc. | $CTMX | Mohindru Mani | Not found | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Cardiff Oncology, Inc. | $CRDF | Mohindru Mani | Director | A | Stock Options | 27700 | $0.00 | 98,501.0000 | 0 | 39.12% | 0.00% |